Determination of ketotifen and its conjugated metabolite in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study

Rapid Commun Mass Spectrom. 2003;17(22):2459-63. doi: 10.1002/rcm.1189.

Abstract

A sensitive and specific liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed for the investigation of the pharmacokinetics of ketotifen and its major metabolite, ketotifen N-glucuronide, in human plasma. The plasma samples were treated by liquid-liquid extraction and analyzed using LC/MS/MS with an electrospray ionization interface. Diphenhydramine was used as the internal standard. The method had a lower limit of quantitation of 10 pg/mL for ketotifen, which offered increased sensitivity, selectivity and speed of analysis, compared with existing methods. The intra- and inter-day precision were measured to be below 8.2% and accuracy between -2.4% and 3.4% for all QC samples. Incubation of the plasma samples with beta-glucuronidase allowed the quantitation of ketotifen N-glucuronide. This quantitation method was successfully applied to a pharmacokinetic study of ketotifen and its major metabolite after oral administration of 2 mg ketotifen fumarate to 16 healthy volunteers.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Calibration
  • Chromatography, Liquid
  • Glucuronides / blood
  • Histamine H1 Antagonists / blood*
  • Histamine H1 Antagonists / pharmacokinetics*
  • Humans
  • Ketotifen / blood*
  • Ketotifen / pharmacokinetics*
  • Male
  • Mass Spectrometry
  • Quality Control
  • Reference Standards
  • Reproducibility of Results
  • Spectrometry, Mass, Electrospray Ionization

Substances

  • Glucuronides
  • Histamine H1 Antagonists
  • Ketotifen